FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

18892611000001100: Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Jun 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64277901000001118 Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64278001000001116 Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Is a Amoxicillin + clavulanate potassium 125mg/31mg/5mL s/f suspension false Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has active ingredient Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Is a Augmentin true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Is a Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free false Inferred relationship Existential restriction modifier
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Is a Co-amoxiclav 125mg/31mg/5ml oral suspension sugar free true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) 100 ml Has AMP True Augmentin 125/31 SF oral suspension (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start